Continuous Glucose Monitoring Global Market Report 2025

The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $8.2 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%./b> The growth during the historic period can be attributed to the rising prevalence of diabetes, increasing awareness of diabetes management, growing demand for real-time glucose monitoring, greater adoption of minimally invasive technologies, and higher healthcare spending in developed nations.

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $16.45 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%./b> The growth in the forecast period can be attributed to the increasing emphasis on personalized and precision medicine, the rising adoption of telehealth and remote patient monitoring, an enhanced focus on preventive healthcare and early diagnosis, greater preference for home-based glucose monitoring, and expanding market penetration in emerging regions. Key trends during the forecast period include miniaturization of implantable devices, development of closed-loop insulin delivery systems, integration with electronic health records, compatibility with fitness trackers and smartwatches, and advancements in skin-adhesive materials.

The increasing prevalence of diabetes is expected to drive the growth of the continuous glucose monitoring market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar (glucose) levels. This rise in diabetes cases is mainly due to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring supports diabetes management by providing real-time blood sugar trends, allowing timely adjustments to diet, medication, and physical activity for better glucose control. For example, in November 2023, the American Diabetes Association, a U.S.-based non-profit organization, reported that in 2022, approximately 25.5 million people in the U.S. - about 7.6% of the population - were diagnosed with diabetes, marking a 3% increase compared to previous years. Thus, the rising prevalence of diabetes is fueling growth in the continuous glucose monitoring market.

Leading companies in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to improve accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors continuously measure blood sugar levels using a small sensor inserted under the skin. For example, in August 2024, DexCom, Inc., a U.S.-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings via a small sensor worn on the back of the upper arm, sending data directly to a smartphone without the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand how factors such as diet, exercise, and sleep affect their glucose levels, enabling smarter lifestyle decisions. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not using insulin, those with prediabetes, or anyone monitoring their glucose health.

In September 2023, Abbott Laboratories, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed sum. Through this acquisition, Abbott seeks to strengthen its position in diabetes care by enhancing its Freestyle Libre continuous glucose monitoring technology and advancing connected solutions to make diabetes management more personalized and precise. Bigfoot Biomedical Inc., also based in the U.S., is a medical technology company that provides a diabetes management system integrating continuous glucose monitoring (CGM) technology.

Major players in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Texas Instruments Inc., Microchip Technology Inc., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Zillion Technologies Inc., Bionime Corporation, Biolinq Inc., Beta Bionics Inc., AgaMatrix Inc., A. Menarini Diagnostics S.r.l, Senseonics Holdings Inc., Medtrum Technologies Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Continuous glucose monitoring (CGM) is a medical technology that continuously measures glucose levels in real time throughout the day and night using a small sensor placed under the skin. It assists people with diabetes in managing their condition by providing ongoing data and alerts for high or low blood sugar levels.

The key components of continuous glucose monitoring systems include transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one point to another for communication or control. These systems are utilized by both adults and children and cater to a range of end users, including hospitals, home care environments, diagnostic centers, clinics, and other healthcare facilities.

The continuous glucose monitoring market research report is one of a series of new reports that cover continuous glucose monitoring market statistics, including the continuous glucose monitoring industry's global market size, regional shares, competitors with the continuous glucose monitoring market share, detailed continuous glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring market. This continuous glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.